15
May
Selegiline and its potential role in treating schizophrenia
In my latest blog post, I explored the potential role of Selegiline in treating schizophrenia. This drug, typically used for Parkinson's disease, has been showing promising results in recent studies for alleviating symptoms of schizophrenia. Selegiline works by inhibiting the breakdown of dopamine, which is believed to have an impact on the positive and negative symptoms experienced by patients with schizophrenia. While more research is needed, Selegiline could potentially become a new treatment option for those suffering from this complex mental illness. Keep an eye out for updates on this fascinating development in the world of mental health!
Read More
0
Comments
